The Omicron Variant with President of Regeneron, George Yancopoulos
StarTalk Radio
00:00
Monoclonal Antibodies and Omicron Challenges
This chapter explores the role of monoclonal antibody treatments for individuals who are unvaccinated or those with insufficient antibody responses. It discusses the significant impact of these treatments on reducing hospitalization and mortality rates, especially among immunocompromised groups, amid the challenges posed by the Omicron variant of COVID-19. The speakers also emphasize the necessity for improved logistics in distributing treatments and the ongoing adaptations required in the fight against evolving virus mutations.
Transcript
Play full episode
